Patients with certain genetic variants may benefit from earlier morning injections if circadian-dependent GLP-1 signaling improves their appetite suppression during waking hours, while others may see equivalent results with evening administration
It does not determine your dose
Recent studies by Amminger, Bell, and Patrick have found that increasing Omega-3s in the diet is associated with improvements in people with ASD, particularly in hyperactivity and repetitive behaviors, as well as cognitive and motor skills, concentration, eye contact, sociability, and sleep
Which Eating Patterns Work, and Which Don't Matter Mediterranean-style, higher-protein, lower-carbohydrate, plant-forward: all of these can support good outcomes on semaglutide
GLP-1 drugs are not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia 2A or 2B